Table 3.

Narrowed racial disparity in graft survival after KT between black and white adults in the United States

Transplant YearLDKTaDDKTb
1-Year aHR (95% CI)3-Year aHR (95% CI)5-Year aHR (95% CI)1-Year aHR (95% CI)3-Year aHR (95% CI)5-Year aHR (95% CI)
1990–19921.28 (0.94 to 1.74)1.44 (1.15 to 1.79)1.53 (1.27 to 1.83)1.06 (0.97 to 1.15)1.30 (1.22 to 1.39)1.39 (1.32 to 1.47)
1993–19941.02 (0.73 to 1.41)1.19 (0.94 to 1.49)1.38 (1.15 to 1.66)0.94 (0.85 to 1.04)1.18 (1.09 to 1.27)1.22 (1.15 to 1.31)
1995–19961.00 (0.73 to 1.36)1.22 (0.98 to 1.51)1.29 (1.08 to 1.54)0.94 (0.84 to 1.05)1.14 (1.05 to 1.24)1.20 (1.12 to 1.28)
1997–19980.80 (0.58 to 1.11)0.94 (0.75 to 1.17)1.04 (0.87 to 1.25)0.93 (0.83 to 1.04)1.08 (0.99 to 1.17)1.16 (1.09 to 1.25)
1999–20001.01 (0.75 to 1.35)1.02 (0.84 to 1.25)1.14 (0.96 to 1.34)0.98 (0.88 to 1.10)1.16 (1.07 to 1.26)1.19 (1.11 to 1.27)
2001–20020.92 (0.69 to 1.21)1.09 (0.90 to 1.31)1.22 (1.04 to 1.42)0.96 (0.86 to 1.08)1.05 (0.96 to 1.13)1.09 (1.02 to 1.17)
2003–20040.86 (0.64 to 1.14)1.02 (0.84 to 1.23)1.15 (0.99 to 1.34)1.05 (0.93 to 1.18)1.18 (1.08 to 1.28)1.15 (1.07 to 1.23)
2005–20060.81 (0.60 to 1.09)0.99 (0.81 to 1.20)1.08 (0.93 to 1.26)0.98 (0.88 to 1.10)1.09 (1.00 to 1.18)1.10 (1.03 to 1.17)
2007–20081.10 (0.80 to 1.51)1.27 (1.04 to 1.56)1.37 (1.17 to 1.61)1.10 (0.98 to 1.24)1.14 (1.05 to 1.24)1.10 (1.03 to 1.18)
2009–20100.86 (0.62 to 1.20)1.05 (0.86 to 1.29)0.85 (0.75 to 0.96)0.98 (0.90 to 1.07)
2011–20120.96 (0.68 to 1.35)0.91 (0.80 to 1.04)
  • The table shows the 1-year, 3-year, and 5-year aHRs comparing all-cause graft loss for blacks versus whites by transplant cohort year, for LDKT and DDKT. —, data not available; DSA, donor service area; PRA/CPRA, panel reactive antibody/calculated panel reactive antibody.

  • a LDKT models adjusted for donor age, donor race/ethnicity, donor relationship, donor/recipient weight ratio, HLA mismatches, peak plasma renin activity (PRA)/CPRA, previous solid organ transplant, recipient age at transplant, recipient body mass index, recipient cause of ESRD, recipient hepatitis C serology, recipient insurance coverage, recipient race/ethnicity, recipient sex, and time on RRT.

  • b DDKT models adjusted for cold ischemia time, donation after circulatory death, donor age, donor cause of death, donor history of diabetes, donor history of hypertension, pumped donor kidney, donor race/ethnicity, donor serum creatinine, donor/recipient weight ratio, HLA mismatches, organ shipped outside recovery DSA, peak PRA/CPRA, previous solid organ transplant, recipient age at transplant, recipient body mass index, recipient cause of ESRD, recipient hepatitis C serology, recipient insurance coverage, recipient race/ethnicity, recipient sex, and time on RRT.